Business Wire

Protegrity Partners With Google Cloud to Support BigQuery Remote Functions

Share

Protegrity, a global leader in data security, today announced it has partnered with Google Cloud to support the upcoming release of BigQuery remote functions. First announced at Google Cloud Next ‘21 in October, BigQuery remote functions offer Google Cloud customers the ability to extend BigQuery with their own external code. With support for remote functions, Protegrity adds an additional layer of data protection, while enabling customers to deliver faster, more robust analysis through Google Cloud BigQuery.

Protegrity’s partnership with Google Cloud lays a strong foundation to deliver de-identified data sets across many Google Cloud services. In addition to its support for Google Cloud remote functions, Protegrity also announced the availability of the Cloud API for Google Cloud, a serverless API that can be used to integrate data protection into cloud services and ETL workflows, as well as the Snowflake Protector on Google Cloud.

“Through our partnership with Google Cloud, one of the foremost leaders in cloud computing and data analytics, we are enabling our mutual customers to accelerate data innovation without compromising privacy,” said Jeffrey Breen, executive vice president of product and strategy at Protegrity. “Joining forces with Google Cloud delivers a privacy-by-design approach to more customers, enhancing their ability to bring to life the value of their sensitive data, pursue secure data collaboration, and innovate through advanced analytics.“

Protegrity’s Support for BigQuery Enables Secure Analytics at Scale
BigQuery’s serverless architecture offers businesses the ability to operate at scale and speed, which allows for faster analytics over large data sets. With Protegrity’s remote functions support, customers can now securely leverage data sets that contain personally identifiable information. In combination with BigQuery’s out-of-the-box security features, Protegrity’s fine-grained data protection gives customers a high level of confidence to achieve compliance with strict data privacy regulations and internal security and risk management policies. This allows businesses to deliver faster, more robust data analysis through BigQuery, without jeopardizing privacy.

Protegrity’s vaultless tokenization uses a data de-identification methodology to protect the privacy of individuals by tokenizing personal identifiers and quasi-identifiers. Tokenizing data before it moves to the cloud delivers a “Security by Design” framework and underpins a customer’s ability to rapidly innovate new applications and analytical models while preserving privacy. Protegrity’s persistent data protection element ensures that data is protected in the case of intrusion, configuration error, or other cases of data exposure.

“As data and analytics have become increasingly important to business growth and innovation, so too has data privacy and security,” said Sudhir Hasbe, Director, Product Management, Google Cloud. “We’re excited for BigQuery remote functions to be generally available for customers and to provide even more ways to run data analysis with speed, privacy, and security in partnership with Protegrity.”

Protegrity’s support for BigQuery remote functions will be generally available in Q1 2022.

Protegrity Cloud API and Snowflake Protector Safeguard Sensitive Data
Protegrity also announced two new data protectors for Google Cloud customers, including the Cloud API, a serverless API that can be used to integrate data protection into cloud services and ETL workflows, as well as the Snowflake Protector on Google Cloud.

  • Cloud API: The Cloud API is a serverless API that allows developers to integrate data protection into custom applications and ETL workflows in the cloud. These components operate on each platform’s native Function-As-A-Service (FaaS) for full cloud, elastic scaling.
  • Snowflake Protector: The Snowflake Protector is a purpose-built protector that integrates seamlessly with Snowflake SQL to protect or unprotect data. It has been benchmarked to blazing speeds with elastic scaling to support the largest workloads.

“In today’s data economy, a company’s competitive advantage lies in their ability to harness the power of the cloud for advanced analytics,” said Matt Hutton, vice president of cloud engineering at Protegrity. “With Protegrity’s advanced data protection capabilities now available for Google Cloud, organizations can generate valuable insights faster and more securely than ever before.”

To learn more about Protegrity’s support for Google Cloud, please visit the blog.

Learn More
Website: protegrity.com
Twitter: @Protegrity
LinkedIn: linkedin.com/company/protegrity/

About Protegrity
Protegrity, a global leader in data security, protects sensitive data everywhere and future-proofs businesses as data-privacy regulations evolve. Maintaining privacy today across distributed data has become impossibly complicated. With Protegrity, enterprises can secure data wherever it resides, control how it’s protected, and have confidence that data is safe, even if a breach occurs. The Protegrity Data Protection Platform is a modern alternative to traditionally complex data-protection methods that leave gaps in security. Whether encrypting, tokenizing, or applying privacy models, Protegrity protects data at the speed of business. Deep integrations with Snowflake, Amazon Redshift, Teradata, Oracle, Microsoft SQL Server, Cloudera, Databricks, and many other enterprise applications ensure that data remains fully protected in hybrid-cloud, multi-cloud, and on-premises environments. The platform’s fine-grained data protection anonymizes personally identifiable information (PII) that’s used in AI and machine learning models, providing faster access to critical analytics data and dramatically shortening the time to business insights. Protegrity protects the sensitive data of more than two billion individuals across global enterprises, including four of the world’s 15 largest banks, four out of 10 of the top health insurance providers, and three of the world’s leading multinational companies. With more than two decades of industry-leading innovation, Protegrity allows businesses to finally tap into the value of their data and accelerate digital transformation timelines – without jeopardizing individuals’ fundamental right to privacy.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Contact:
Andrew Smith
Bhava Communications for Protegrity protegrity@bhavacom.com
+1 (310) 941-7251

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

LintonPharm to Release Data on Catumaxomab for Advanced Gastric Cancer with Peritoneal Metastasis at 2022 ASCO Annual Meeting27.5.2022 15:00:00 CEST | Press release

LintonPharm Co., Ltd., a China-based biopharmaceutical company focusing on the development of T cell engaging bispecific antibodies for cancer immunotherapy, announces that preliminary results of Catumaxomab for advanced Gastric Cancer (GC) with peritoneal metastasis is published online at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting. Abstract Number:e16102 Abstract Title:Global multi-center phase I trial of the intraperitoneal infusion of anti-EpCAM x anti-CD3 bispecific antibody catumaxomab for advanced gastric carcinoma with peritoneal metastasis. The abstract is about the cohort A, stage I of the ongoing global phase Ⅲ trial that evaluating the safety and efficacy of Catumaxomab in advanced GC patients with peritoneal metastasis (clinicaltrials.gov: NCT04222114). Worldwide, GC is one of the most common cancers, contributing to more than 1 million cases per year and 5.6% of all cancer diagnoses [1]. Approximately 50% of the advanced GC patients will develop p

FEELM unveils the world's first ceramic coil disposable pod solution at Vaper Expo UK 202227.5.2022 13:38:00 CEST | Press release

FEELM, the flagship atomization tech brand belonging to SMOORE, today showcased the world's first ceramic coil disposable pod solution series, FEELM Max at Vaper Expo UK 2022 in Birmingham, UK. By launching the solution and showcasing its cutting-edge ceramic coil heating technology, FEELM is introducing ceramic coil to the emerging category of disposable vape. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220527005197/en/ (Photo: Business Wire) As a new category in the ascendant, the disposable vape has been growing in popularity since 2020. The market size of disposable (closed system) vaping product has grown to approximately USD2.125 billion in 2021, accounting for 22.7% of global vaping device market share; and it is expected to increase at a GAGR of over 28% from 2022 to 2026, being the fastest-growing category among all vaping products, according to the estimates of Frost & Suvillian. In 2022, the market size of disp

Mavenir’s Containerized Open vRAN Small Cell Solution Wins Award for Outstanding Contribution to Emerging Technology or Architecture27.5.2022 09:00:00 CEST | Press release

Mavenir, the Network Software Provider building the future of networks with cloud-native software that runs on any cloud and transforms the way the world connects, today announced to have won the SCF Small Cell Awards 2022 for Outstanding Contribution to Emerging Technology or Architecture, for its design and delivery of the first fully containerized small cell Open Virtualized Radio Access Network (Open vRAN), for indoor and outdoor connectivity. Mavenir’s containerized Open vRAN solution is a first of its kind and combines the interoperability of Open RAN with the portability and flexibility of containers. This small cell solution brings the same future-forward approaches of Open RAN and containerization having significant impacts in macro networks to small cell networks. The deployment of a containerized solution is a significant milestone in the evolution of connectivity, moving away from the physical infrastructure to a digital cloud-based environment. Containers take virtualizati

TYAN Brings Modern HPC Server Platforms for Data Centers at ISC 202227.5.2022 09:00:00 CEST | Press release

TYAN®, an industry-leading server platform design manufacturer and MiTAC Computing Technology Corporation subsidiary, will exhibit its latest HPC platforms powered by 3rd Gen AMD EPYC™ Processors with AMD 3D V-Cache™ technology for data centers deployments at the ISC 2022 event from May 30th to June 1st at booth #D400. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220527005002/en/ TYAN’s Server Platforms Powered by AMD EPYC 7003 Series Processors Provide the Best Foundation for Data Centers that Can be Tailored to Specific Workloads (Photo: Business Wire) “The amount of data generated by humans and machines has increased exponentially and this requires a steady increase of data center compute performance, therefore, modern data centers need balanced hardware to efficiently manage growing data volumes,” said Danny Hsu, Vice President of MiTAC Computing Technology Corporation's Server Infrastructure Business Unit. “TYAN’s ser

Takeda and Seagen to Highlight ADCETRIS ® Combination Data Showing Statistically Significant Improvement in Overall Survival (OS) for Patients with Advanced Hodgkin Lymphoma26.5.2022 23:25:00 CEST | Press release

Takeda Pharmaceutical Company Limited (TSE:4502) and Seagen Inc., (NASDAQ:SGEN) today announced that overall survival (OS) data from the Phase 3 ECHELON-1 clinical trial of an ADCETRIS® (brentuximab vedotin) plus chemotherapy combination will be presented in an oral session at the 59th American Society of Clinical Oncology (ASCO) Annual Meeting on Friday, June 3, 2022, 1:00-4:00 PM CT, and at the 27th European Hematology Association (EHA) Annual Meeting on Friday, June 10, 2022, 11:30 – 12:45 CEST. “The longer-term follow-up data from the ECHELON-1 trial have significant clinical importance, as this trial represents one of only two frontline randomized studies in advanced stage Hodgkin lymphoma that shows an overall survival advantage for the experimental arm,” said Stephen Ansell, M.D., Ph.D., Mayo Clinic, and ECHELON-1 study investigator. “These results clearly show that the addition of brentuximab vedotin to chemotherapy improves the long-term outcome of patients and the combination